{"id":"W2326180271","doi":"10.1097/01.mib.0000480258.39258.e5","title":"P-103 Refinement of Population Pharmacokinetic Model of Certolizumab Pegol in Crohnʼs Disease Patients to Account for Time Varying Nature of Covariates","year":2016,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"NONMEM; Certolizumab pegol; Covariate; Pharmacokinetics; Medicine; Population; Volume of distribution; Population pharmacokinetics; Percentile; Internal medicine; Pharmacology; Statistics; Disease; Mathematics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002743728,0.0007912136,0.001250683,0.0004425704,0.0003019615,0.000937646,0.001264421,0.0008845082,0.00185374],"category_scores_gemma":[0.005502888,0.0006641785,0.001797082,0.0004337082,0.0003094179,0.0005643035,0.0007617134,0.00176672,0.0003793325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007916722,"about_ca_system_score_gemma":0.002263962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01963663,"about_ca_topic_score_gemma":0.009442304,"domain_scores_codex":[0.9992056,0.0004249821,0.00003793012,0.000177136,0.00008145716,0.00007286712],"domain_scores_gemma":[0.9980193,0.001402079,0.0002128547,0.0001063077,0.0002053464,0.00005409417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0002904298,0.00009118861,0.0221847,0.00007678198,0.0003313349,0.000608343,0.0001257862,0.9494839,0.00158502,0.002923792,0.001246124,0.02105262],"study_design_scores_gemma":[0.0000310602,0.00007833297,0.002291457,0.00000627186,0.00004645694,0.00009822167,0.000007281482,0.9956638,0.0001956914,0.0009168758,0.0006558255,0.000008817049],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.2909543,0.0006550926,0.7021771,0.0009348255,0.00009182934,0.000288479,0.001671539,0.0008088824,0.002417936],"genre_scores_gemma":[0.9195555,0.000396793,0.07239498,0.000283846,0.00007931433,0.0006106228,0.001590591,0.0001500896,0.004938276],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01963663,"threshold_uncertainty_score":0.03904468,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01464632109651604,"score_gpt":0.3014544955361113,"score_spread":0.2868081744395952,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}